Related Experiment Video
Updated: Aug 24, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Published on: February 2, 2024
Precision Pancreatic Cancer Care: From Early Detection to Adaptive Precision Oncology
Takehiro Okabayashi1, Motoyasu Tabuchi1, Teppei Tokumaru1
1Department of Gastroenterological Surgery, Kochi Health Sciences Center, Kochi, Japan.
Background:
Pancreatic ductal adenocarcinoma (PDAC) remains highly lethal, and genome-centric precision oncology shows limited impact due to low actionable alterations and high heterogeneity.
Recent Findings:
A broader "Precision Pancreatic Cancer Care" (PPCC) framework integrates multi-omics, spatial biology, and patient-derived organoids to enhance early detection and functional oncology. Longitudinal molecular monitoring, microenvironment targeting, and personalized supportive care are vital to combating therapeutic resistance.
Conclusion:
Shifting from isolated genomic profiling to a multidimensional, adaptive ecosystem across the entire disease continuum holds the potential to transform PDAC management and improve patient outcomes.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Survival Analysis
Chronic Pancreatitis II: Collaborative Care
Assessment:
